Explore / Clinical trial
Clinical trial

Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition

Hoffmann-La RocheCompletedStarted Dec 7, 2015223 enrolledSpainNCT02598167

Abstract

This multi-center non-interventional, observational, cross-sectional study in adult participants with relapsing remitting multiple sclerosis (RRMS) will evaluate the participants' preferences for disease modifying treatments (DMT) in routine clinical practice.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

DMT

Keywords

Multiple Sclerosis, Relapsing-Remitting

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.